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Superovulation of Beef Heifers with Follicle Stimulating Hormone or
Human Menopausal Gonadotropin: Acute Effects on Hormone Secretion
Abstract
The effects of superovulatory treatment (follicle stimulating hormone [FSH] versus human menopausal
gonadotropin [HMG]) and of route of administration (intramuscular versus intravenous) of prostaglandin
F2a (PGF2a) on hormonal profiles were determined in 32 Angus x Hereford heifers for breeding and
subsequent embryo collection and transfer. Heifers were superstimulated either with FSH (total of 26
milligrams) or HMG (total of 1,050 international units) beginning on days 9 to 12 of an estrous cycle and
PGF2a (40 milligrams) was administered at 60 and 72 hours after the beginning of superovulatory treatments.
Heifers were artificially inseminated three times at 12-hour intervals beginning 48 hours after PGF2a
treatment. Blood serum samples were collected immediately before treatments began and at frequent intervals
until embryo collection 288 hours later. Concentrations of luteinizing hormone (LH) and FSH were not
affected by hormone treatments, route of PGF2a injection, or interactions between them. Estradiol-17ß
(E2-17ß) levels were higher in HMG- than in FSH-treated heifers 60 hours after gonadotropin treatment.
Peak concentration of E2-17ß occurred earlier in HMGthan in FSH-treated heifers and earlier in heifers
injected with PGF2a intramuscularly than those injected intravenously. Progesterone concentrations were not
influenced by treatment or route of PGF2a administration. The progesterone:E2-17ß ratio was higher in FSH-
than in HMG-treated heifers 24 hours after the LH peak. The high steroid hormone concentrations in
superovulated beef heifers before and after ovulation may lead to asynchrony between stages of embryonic
development, a situation that may interfere with the pregnancy outcome of superovulated embryos in
recipient animals.
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Summary
The effects of superovulatory treatment (follicle
stimulating hormone [FSH] versus human
menopausal gonadotropin [HMG]) and of route of
administration (intramuscular versus intravenous) of
prostaglandin F2a (PGF2a) on hormonal profiles were
determined in 32 Angus x Hereford heifers for
breeding and subsequent embryo collection and
transfer. Heifers were superstimulated either with
FSH (total of 26 milligrams) or HMG (total of 1,050
international units) beginning on days 9 to 12 of an
estrous cycle and PGF2a (40 milligrams) was adminis-
tered at 60 and 72 hours after the beginning of
superovulatory treatments. Heifers were artificially
inseminated three times at 12-hour intervals
beginning 48 hours after PGF2a treatment. Blood
serum samples were collected immediately before
treatments began and at frequent intervals until
embryo collection 288 hours later. Concentrations of
luteinizing hormone (LH) and FSH were not affected
by hormone treatments, route of PGF2a injection, or
interactions between them. Estradiol-17ß (E2-17ß)
levels were higher in HMG- than in FSH-treated
heifers 60 hours after gonadotropin treatment. Peak
concentration of E2-17ß occurred earlier in HMG-
than in FSH-treated heifers and earlier in heifers
injected with PGF2a intramuscularly than those
injected intravenously. Progesterone concentrations
were not influenced by treatment or route of PGF2a
administration. The progesterone:E2-17ß ratio was
higher in FSH- than in HMG-treated heifers 24 hours
after the LH peak. The high steroid hormone
concentrations in superovulated beef heifers before
and after ovulation may lead to asynchrony between
stages of embryonic development, a situation that
may interfere with the pregnancy outcome of
superovulated embryos in recipient animals.
Introduction
The response in quantity and quality of embryos
obtained after superovulation of cattle remains variable
and continues to represent a limiting factor in the
development of successful embryo transfer programs. This
__________________________
*Deceased.
variability in ovarian response has been attributed to
genetic factors, dynamics of follicular growth, and
differences in luteinizing hormone (LH)- and follicle
stimulating hormone (FSH)-specific activities of
gonadotropin preparations.
Most of the available information on endocrine
changes in superstimulated heifers has been obtained
either with pregnant mare serum gonadotropin (PMSG) or
pituitary extracts containing FSH. The effectiveness of
human menopausal gonadotropin (HMG) as a
superovulatory hormone treatment in cattle has been
studied, and no differences in ovarian responses have
been found when HMG has been compared to FSH or to
PMSG. Prostaglandin F2a (PGF2a) commonly is adminis-
tered to superstimulated donors to control the time of
estrus and ovulation, and intravenous injection of PGF2a
or a prostaglandin analog seems to favor an endocrine
balance and uterine environment compatible with the
development of superovulated ova. The objectives of this
study were to determine whether superovulatory
treatment (FSH versus HMG) and route of administration
of PGF2a (intramuscular versus intravenous) influence
the concentration of LH, FSH, estradiol-17ß (E2-17ß), or
progesterone in peripheral blood serum of embryo donor
beef heifers.
Materials and Methods
Experimental Animals and Superovulatory Treatments  
Thirty-two Angus x Hereford heifers (352 –  8 kilo-
grams body weight; mean –  standard error) were supers-
timulated beginning on day 9 to 12 of an estrous cycle.
Heifers were divided into two groups of 16 each. Each
group was superstimulated either with FSH (total dose of
26 milligrams per heifer; Burns Biotec Laboratories Inc.,
Omaha, Neb.) or HMG (Pergonal®; total dose of 1,050
international units heifer; Serono Laboratories Inc.,
Braintree, Mass.). The FSH was injected intramuscularly
at a dosage of 4, 4; 3, 3; 3, 3; 2, 2; and 1, 1 milligram
a.m. and p.m. per day for five days; HMG was injected
intramuscularly at a dosage of 2, 2; 2, 2; 1, 1; 1, 1; and
1, 1 ampoules (1 ampoule = 75 international units FSH
activity and 75 international units LH activity) a.m. and
p.m. per day for five days. Sixty hours after gonadotropin
treatment began, eight females from each group received
25 milligrams of PGF2a (Lutalyse®; Upjohn Co.,
Kalamazoo, Mich.) either intramuscularly or intravenous-
ly, and 12 hours later, another 15 milligrams of the hor-
mone was given by the same route. Heifers were checked
for estrus twice daily, and 60 hours after first PGF2a
injection they were inseminated three times at 12-hour
intervals. A blood sample from the jugular vein was
collected immediately before treatment began, at 12-hour
intervals during the first 60 hours, each 4 hours during the
next 96 hours, and each 12 hours until the day (a.m.) of
embryo collection (Figure 1).
Radioimmunoassay of Gonadotropins and Steroid Hor-
mones
Luteinizing hormone was measured by radioimmuno-
assay using highly purified bovine LH (bLH, NIH) for
both radioiodination with 125I and for standards (25 picog-
rams to 20 nanograms). Assay sensitivity averaged .2
nanograms per milliliter. Intra- and interassay coefficient
of variance were 8.0 and 4.8%, respectively. The FSH
was measured using USDA FSH-BP1 as the standard.
The coefficients of variance for samples containing 14
nanograms per milliliter within assay was 18% and be-
tween assay was 17.2%. Progesterone was solvent ex-
tracted and percent recovery averaged 90%; sensitivity of
the assay was 100 picograms per milliliter. Intra- and
interassay coefficients of variance were 9.0 and 11.0%,
respectively. Estradiol-17ß was extracted and measured
as we previously described. Sensitivity of the assay was 2
picograms. The intra- and interassay coefficients of vari-
ance were 12.8 and 12.6%, respectively.
Statistical Analysis
Data were analyzed by split-plot analysis of
variance.
Results and Discussion
We focused on the endocrine changes that occurred
in embryo donor beef heifers superovulated with FSH and
HMG and injected intramuscularly or intravenously with
PGF2a. We observed no significant differences in the
numbers of corpora lutea, oocytes, or embryos recovered
nor of transferrable embryos after treatment either with
FSH or HMG. Embryos obtained from HMG-treated beef
heifers established fewer pregnancies, however, than did
those from FSH-treated heifers. The circulating concen-
trations of LH, FSH, progesterone, and E2-17ß in these
heifers are presented in Figure 2.
Luteinizing Hormone
Concentrations of LH were not influenced by treat-
ment, route of PGF2a administration, or interactions
between them. Interval from PGF2a injection to LH peak
was affected by gonadotropin treatment (p < .05) and
route of PGF2a administration (p < .01). Luteinizing
hormone peaked earlier (p < .05) in HMG- (47 –  3 hours)
than in FSH- (54 –  3 hours) treated animals, and those
injected intramuscularly with PGF2a had the LH peak
earlier (45 –  3 hours) than those injected intravenously
(57 –  3 hours; p < .01). Peak concentrations of serum LH
were not affected by treatment or route of PGF2a
administration (Table 1). The peak LH concentration
averaged 147 –  16 nanograms per milliliters (range 28 to
430) in 31 of 32 heifers. Luteinizing hormone peak
concentration, area under the LH peak, and interval from
PGF2a to LH peak were not correlated with the number of
corpora lutea palpated, number of oocytes or embryos
collected, or number of transferrable embryos.
Follicle-Stimulating Hormone
Concentrations of FSH were not affected by treat-
ment, route of PGF2a administration, nor the interaction
between them (Figure 2); however, there was an interac-
tion (p < .01) between time and treatment and between
time and route of PGF2a injection. Concentrations of FSH
increased (p < .01) 24 hours after initial FSH-, but not
after HMG-injection. The assay used here, however,
could not differentiate endogenous from exogenous
gonadotropins. Concentrations of FSH peaked near estrus
and decreased abruptly afterward (Figure 2 and Table 1).
Interval from PGF2a to the FSH peak was affected by
treatment (p < .05; 49 –  2 hours in HMG versus 55 –  3
hours in FSH) and route of PGF2a administration (p <
.01; 47 –  2 hours for intramuscular versus 57 –  3 hours for
intravenous (Table 1). Peak concentrations of FSH were
not affected by treatment, route of PGF2a administration,
or interactions between them (Table 1). In this study, 28
of 32 heifers had synchronous LH and FSH peaks. The
LH:FSH peak height ratio was similar among treatments
and route of PGF2a administration.
Progesterone
In this study, progesterone concentrations were not
affected by treatment or route of PGF2a administration. A
slightly greater increase in progesterone concentrations
was seen in the HMG- (twofold) than in the FSH- (1.2-
fold) treated heifers 48 hours after gonadotropin treat-
ment, reflecting a possible stimulatory effect of HMG on
development of the corpora lutea, perhaps due to its LH-
like activity.
Progesterone concentrations dropped markedly after
PGF2a administration and remained low throughout estrus
(Figure 2). Progesterone increased steadily after ovula-
tion until the day of embryo collection in most of the
heifers. When progesterone concentrations were adjusted
to coincide with the LH peak and compared 24 hours
before and after it, there was an interaction between
treatment and time of LH peak on progesterone
concentrations. The FSH-treated heifers injected
intravenously with PGF2a reached basal progesterone
levels earlier (p < .05) and were lower (.2 nanograms per
milliliters) at 12 hours after the LH peak than heifers
from the other treatment groups (.6 nanograms per
milliliter). Twenty-four hours after the LH peak,
progesterone levels began to increase in FSH-treated
heifers but they remained at basal concentrations in
HMG-treated animals. Progesterone concentrations in
superstimulated beef heifers were positively correlated (r
= .46; p < .01) with the number of corpora lutea 64 hours
after a synchronous LH and FSH peak and were
maintained until the day of embryo collection (r = .59; p
< .01). We collected 56 embryos (22% of the total 262)
from five of six animals, most of which (52/56) were
morphologically normal morula and blastocysts. Sixteen
of these 52 embryos were transferred to recipients (17%
of the total number of embryos transferred, 16/93), and 14
of the 16 transferred embryos did not develop into fetuses.
Estradiol-17ß 
Treatment of heifers with FSH- or HMG influences
(p < .05) E2-17ß concentrations in peripheral serum, but
concentrations were not influenced by route of PGF2a
administration. Concentrations of E2-17ß were affected by
time (p < .01), interaction between time and treatment (p
< .01), and interaction between time and route of PGF2a
administration (p < .01). Preovulatory E2-17ß levels
began to increase steadily (p < .05) after 24 hours from
initial injection of HMG and 48 to 60 hours after initial
injection of FSH. Sixty hours after initial superovulatory
treatment, E2-17ß levels had increased seven-fold in the
HMG group and had doubled in the FSH group. It is
likely that this increase in estrogen concentration results
from increased follicular growth stimulated by the gonad-
otropins. Concentrations of E2-17ß decreased markedly at
time of the LH peak and remained low until the time of
embryo collection (Figure 2). The interval from PGF2a to
E2-17ß peak was less (p < .05) in HMG- (44 –  3 hours
than in FSH (52 –  2 hours) treated heifers after initial
injection of PGF2a. Animals injected with PGF2a intram-
uscularly reached (p < .01) peak concentrations of E2-17ß
43 –  3 hours after PGF2a  injection; those injected
intravenously reached peak concentrations 53 –  2 hours
after PGF2a treatment. The earlier estradiol increase in
HMG-treated heifers may have contributed to the earlier
(p < .05) estrus seen in the HMG-treated animals (Table
1). Peak concentrations of E217-ß were not different
between treatments or route of PGF2a (Table 1). Estradi-
ol-17ß peak concentrations were correlated with the num-
ber or corpora lutea (r = .47; p < .01) and with the
number of embryos or oocytes recovered (r = .61; p <
.01). The preovulatory estrogen concentrations have been
suggested to be more useful in predicting follicular re-
sponse of individual donors than postovulatory progester-
one concentrations. The delay in the initial preovulatory
increase of E2-17ß that we observed in the FSH-treated
heifers but not in the HMG-treated heifers suggests that a
lag period for follicular maturation is needed during FSH
stimulation of the ovaries. This could translate into higher
pregnancy rates in recipients of embryos obtained from
FSH-injected heifers. Moreover, the relative concentra-
tions of both progesterone and E2-17ß after the LH peak
may also explain the reduced pregnancy rates with
embryos derived from HMG-treated heifers.
In summary, we report here that superstimulation of
heifers with FSH or HMG influences circulating concen-
trations of E2-17ß but not of LH, FSH, or progesterone.
Route of PGF2a administration did not significantly affect
these hormone secretion patterns, although significant
interactions between treatment and route of PGF2a injec-
tion were observed on progesterone serum concentrations
when coincident with the time of the LH peak.
Implications
The high steroid hormone concentrations in su-
perovulated beef heifers before and after ovulation
may lead to asynchrony between stages of
embryonic development, a situation that may
interfere with the pregnancy outcome of super-
ovulated embryos in recipient animals.
Table 1.  Hours ( –  SEM) from prostaglandin F2 a  (PGF2 a ) injection to estrus, and to luteinizing hormone
(LH), follicle-stimulating hormone (FSH), and estradiol 17- b  (E2-17 b  ) peaks and preovulatory peak
concentrations.
a
 Main effect of gonadotropin, p < .05; route of PGF2 a )  p <.01>
b,c
 Numbers within columns with different superscripts are different at p <.05 for gonadotropin treatments.*
Figure 1. Experimental design for induction of superovulation, breeding, and embryo collection in
beef heifers. Blood collection intervals are described in the Materials and Methods section. AI =
artificial insemination; PGF2a = prostaglandin F2a; FSH = follicle-stimulating hormone.
Figure 2. Mean concentrations of progesterone (o), follicle-stimulating hormone (FSH, _), and
estradiol-17ß (l) in peripheral serum of beef heifers superovulated either with FSH-P or human
menopausal gonadotropin and then injected intravenously or intramuscularly with PGF2a, as
described in the Materials and Methods section. The pooled SE for progesterone is 1.8 nanograms
per milliliters, for estradiol-17ß is 2.1 picograms per milliliters, and for FSH is 2.2 nanograms per
milliliters.
